Suppr超能文献

相似文献

1
Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection.
Cell Host Microbe. 2023 Sep 13;31(9):1552-1567.e8. doi: 10.1016/j.chom.2023.08.001. Epub 2023 Aug 30.
6
The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.
Cancer Immunol Res. 2024 Jun 4;12(6):663-672. doi: 10.1158/2326-6066.CIR-23-1078.
7
Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling.
Hum Mol Genet. 2024 Sep 3;33(18):1555-1566. doi: 10.1093/hmg/ddae089.
8
cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing.
Mol Cell. 2021 Feb 18;81(4):739-755.e7. doi: 10.1016/j.molcel.2021.01.024.
9
TREX1 as a Novel Immunotherapeutic Target.
Front Immunol. 2021 Apr 1;12:660184. doi: 10.3389/fimmu.2021.660184. eCollection 2021.
10
Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection.
Nat Commun. 2020 Jan 9;11(1):164. doi: 10.1038/s41467-019-13965-x.

引用本文的文献

1
Advancements in CRISPR/Cas systems for disease treatment.
Acta Pharm Sin B. 2025 Jun;15(6):2818-2844. doi: 10.1016/j.apsb.2025.05.007. Epub 2025 May 17.
2
SARS-CoV-2 infection induces ZBP1-dependent PANoptosis in bystander cells.
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2500208122. doi: 10.1073/pnas.2500208122. Epub 2025 Jul 8.
4
IFIT3 RNA-binding activity promotes influenza A virus infection and translation efficiency.
J Virol. 2025 Jul 22;99(7):e0028625. doi: 10.1128/jvi.00286-25. Epub 2025 Jun 11.
6
Deep mutational scanning and CRISPR-engineered viruses: tools for evolutionary and functional genomics studies.
mSphere. 2025 May 27;10(5):e0050824. doi: 10.1128/msphere.00508-24. Epub 2025 Apr 24.
7
Influenza virus antagonizes self sensing by RIG-I to enhance viral replication.
bioRxiv. 2025 Mar 12:2025.03.12.642847. doi: 10.1101/2025.03.12.642847.
8
Cellular SLC35B4 promotes internalization during influenza A virus entry.
mBio. 2025 May 14;16(5):e0019425. doi: 10.1128/mbio.00194-25. Epub 2025 Mar 25.
9
Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapy.
Signal Transduct Target Ther. 2025 Mar 19;10(1):90. doi: 10.1038/s41392-025-02174-2.
10
IFIT3 RNA-binding activity promotes influenza A virus infection and translation efficiency.
bioRxiv. 2025 Apr 12:2025.02.17.638785. doi: 10.1101/2025.02.17.638785.

本文引用的文献

1
Alternative splicing liberates a cryptic cytoplasmic isoform of mitochondrial MECR that antagonizes influenza virus.
PLoS Biol. 2022 Dec 21;20(12):e3001934. doi: 10.1371/journal.pbio.3001934. eCollection 2022 Dec.
2
Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection.
Nat Commun. 2022 Oct 29;13(1):6456. doi: 10.1038/s41467-022-34111-0.
3
Retasking of canonical antiviral factors into proviral effectors.
Curr Opin Virol. 2022 Oct;56:101271. doi: 10.1016/j.coviro.2022.101271. Epub 2022 Oct 13.
4
Influenza A virus undergoes compartmentalized replication in vivo dominated by stochastic bottlenecks.
Nat Commun. 2022 Jun 14;13(1):3416. doi: 10.1038/s41467-022-31147-0.
6
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
Nature. 2022 Mar;603(7899):145-151. doi: 10.1038/s41586-022-04421-w. Epub 2022 Jan 19.
7
From high-throughput to therapeutic: host-directed interventions against influenza viruses.
Curr Opin Virol. 2022 Apr;53:101198. doi: 10.1016/j.coviro.2021.12.014. Epub 2022 Jan 11.
9
The type I interferonopathies: 10 years on.
Nat Rev Immunol. 2022 Aug;22(8):471-483. doi: 10.1038/s41577-021-00633-9. Epub 2021 Oct 20.
10
Pharmacological activation of STING blocks SARS-CoV-2 infection.
Sci Immunol. 2021 May 18;6(59). doi: 10.1126/sciimmunol.abi9007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验